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Abstract Study Design Randomized controlled trial.
Objective Adolescent idiopathic scoliosis (AIS) is a common spinal deformity that
affects every population. In severe deformity, surgical intervention is performed.
Autogenous iliac crest bone graft (ICBG) harvesting remains a common procedure
worldwide for scoliosis surgery. Postoperative pain at the ICBG donor site is a major
concern in patients undergoing spine surgery that affects postoperative functional
outcome and consumes health care resources. Previous studies have noted a decrease in
pain and postoperative analgesic use with the application of continuous infusion of
anesthetic at the ICBG site in comparison with placebo. However, there is lack of
evidence addressing the efﬁcacy of continuous anesthetic infusion at the ICBG site in
young patients and in particular those with spinal deformity, such as AIS. As such, this
parallel, double-blinded, randomized controlled trial addressed the pain management
efﬁcacy of continuous anesthetic infusion versus saline at the ICBG site in patients with
AIS during the immediate postoperative period.
Methods Participants were randomized into two groups. Group A (control subjects)
received 3 mL per hour of saline locally at the ICBG site, and group B (treatment
subjects) received a constant rate of infusion of 3mL per hour of 0.25% levobupivacaine.
Both groups received their postoperative intervention for 47 hours. All subjects and
outcome assessors were blinded to the type of intervention. Utilizing the visual analog
pain scale, pain was assessed at the primary spine surgical site, ICBG site, and
contralateral ICBG site. Overall physical pain was assessed by the McGill Pain Question-
naire. The degree of analgesic use and complications were also evaluated. All outcomes
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Adolescent idiopathic scoliosis (AIS) is a common spinal
deformity that occurs in every population worldwide.1 For
severe curves, surgical intervention is sought to decrease the
deformity and improve daily function. As such, spinal fusion
procedures are commonly performed and often entail the use
of autogenous iliac crest bone graft (ICBG).2
The iliac crest is a common donor site for autograft bone
harvesting in spine surgery procedures due to its easy access
and high structural integrity; it is an excellent source for cortical
and cancellous bone.3 However, various complications are
associated with autologous ICBG harvesting and include poten-
tial injury to the neurovascular structures, donor site visceral
herniation, fracture or pelvic instability, hematoma, sensory
disturbances, deep wound infections, and cosmetic deformi-
ty.4–6 A major concern following bone harvesting from the
anterior or posterior iliac crest is postoperative donor site
pain.3,4,6–9 The incidence of postoperative iliac crest donor
site pain varies, depending on the postoperative time interval,
technique of assessment, location of the donor site, primary
surgical site, and methodological study limitations.10 Nonethe-
less, such pain has been reported to occur in 2.8 to 49% of
cases.3,6–8 However, studies have noted that up to 39% of the
patients undergoing ICBG harvesting reported chronic postop-
erative pain (3 months or greater) stemming from the donor
site.3,4,7 As a result, functional activity could be impaired,
affecting ambulation, recreational and daily living activities,
work and professional duties, and sexual activity.4 Such donor
site pain could also have severe pharmacologic implications
from prolonged use of analgesic medication, which is also
fraught with potential complications (e.g., dependency, nausea,
vomiting, dizziness, increased health care costs, etc.).4However,
in an effort to reduce or prevent postoperative iliac crest donor
site pain, several surgical techniques have been proposed
regarding variation in harvesting methods and reconstruction
of the donor site.3Nonetheless, such techniques were not found
to conclusively improve postoperative iliac crest donor site pain.
The application of an anesthetic agent (e.g., bupivacaine)
on non–iliac crest-speciﬁc wound sites in orthopedic and
other surgical procedures was found to decrease postopera-
tive pain and narcotic usage,11 but a consistent, signiﬁcant
difference between the anesthetic and saline or control in
some studies has not been clearly demonstrated, which
suggests that anesthetic analgesic control may depend on
the operative site.12 Nonetheless, various studies have noted
that the analgesic effects associated with local anesthetic
application seem to outlast the expected duration of the
anesthetic agent.13 Several authors contend that such effects
in deep tissue injuries are possibly attributed to the decrease
of spinal cord receptor ﬁeld changes and hyperexcitability
due to the immediate reduction of noxious afferent input
afforded by local anesthetic application.14
Several randomized and nonrandomized prospective
studies have noted that the application of an anesthetic agent
on the donor site following bone graft harvesting from the
iliac crest to address non-spine-speciﬁc procedures resulted
in decreased postoperative donor site pain, analgesic use, and
hospitalization.15 Studies have also noted that application of
donor site anesthetic immediately following surgery not only
improves pain in the postoperative short term, but signiﬁ-
cantly improves long-term pain in comparison with individ-
uals without such intervention.16 Furthermore, based on
randomized controlled trials, the use of continuous anesthet-
ic infusion on the donor site, including the ICBG site, has
demonstrated a reduction in postoperative pain and analgesic
use in adults.9,15,17–19 Thus, such effects may conceivably
translate into reduced health care costs and a quicker return
to daily activities.4
Based on the literature, the postoperative pain manage-
ment of the ICBG donor site in children who receive surgical
treatment for AIS remains in contention, which is of particu-
lar importance because recent studies have noted that the
rate of postoperative acute pain in children undergoing
orthopedic procedures is 84% (13% chronic pain) and that
over 30% of subjects reported that such pain interferes with
Results Twelve subjects were recruited (ﬁve in group A; seven in group B). No
difference was noted at baseline regarding age, weight, height, arm span, sex, curve
type, instrumented and fused levels, length of hospitalization, and pain scores between
groups. Postoperatively, no difference was noted in surgical site pain between groups
(p > 0.05). However, decreased ICBG and contralateral ICBG pain decreased twofold in
group B patients in comparison with group A. Similarly, group B subjects had notably
decreased postoperative overall pain scores (group A, mean 15.3; group B, mean 3.8).
No signiﬁcant differences were noted for the pain scores due to the small sample size.
Conclusions This study is the ﬁrst with a robust level I study design to assess the
efﬁcacy of continuous infusion of analgesia into the ICBG site in young patients with AIS.
This pilot study noted a trend that continuous anesthetic infusion reduces pain at the
ICBG site and may further decrease overall physical bodily pain. This study further
established a sample size calculation to facilitate large-scale studies addressing these
parameters. This study provides further support of postoperative pain management
options for children with spinal deformities.
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their sleep, social functioning, and extracurricular activi-
ties.20 According to Skaggs et al,2 the authors noted that in
children undergoing spinal fusion who underwent posterior
ICBG, 24% reported donor site pain and 15% noted that the
pain was severe enough to interfere with daily activities even
up to a mean of 55 months after surgery. Furthermore,
although not fully understood, childhood pain experiences
may “increase” the riskof psychological issues in adulthood.21
In many centers around the world, ICBG is still harvested
for various spine surgeries, including procedures to treat
AIS.22–25 As such, we conducted a double-blinded, random-
ized controlled clinical trial to address the immediate efﬁcacy
of postoperative pain management comparing continuous
infusion of saline to anesthetic at the posterior ICBG donor
site in patients with AIS.
Methods
Study Design and Participants
This study was a parallel, double-blinded, randomized con-
trolled trial of participants of Southern Chinese origin with
AIS undergoing posterior spinal fusion with autogenous
posterior ICBG at the Duchess of Kent Children’s Hospital in
Pokfulam, Hong Kong. Each subject was screened to deter-
mine eligibility for the study. Participants who weighed less
than 35 kg were excluded due to the fear ofmedical overdose.
Individuals who had undergone previous spine surgery and/
or ICBG harvesting, had known allergies to levobupivacaine
and morphine, were pregnant or lactating, had infection at
the site of bone graft harvesting, had a history of blood
coagulation disorders or pulmonary embolism, had known
psychological disorders, and had any additional comorbid-
ities or criteria that led the investigators to believe that the
subject may not comply with the study protocol were exclud-
ed. All participants were between 10 to 18 years of age at the
time of surgery.
The study was approved by the Institutional Review Board
of The University of Hong Kong and the Hong Kong West
Clusters Hospital of the Hospital Authority andwas registered
with Hong Kong Clinical Trials (HKCTR-1247). Participation
was voluntary, and informed consent was obtained from all
subjects as well as their guardians. The protocol of the study
was described to all subjects at the time of recruitment, and
documentation was provided to them in a language they
understood, noting that at any time during the study they had
the right to withdraw without justiﬁcation.
Sample Size
Due to the absence of similar trial designs addressing the
stated parameters in children with AIS, there was a lack of
evidence to facilitate the sample size calculation with conﬁ-
dence. As such, our initial recruitment of participants served
as a pilot study.
Operative Procedure
All subjects were placed prone in a knee–chest position and
underwent posterior instrumentation and fusion. Through a
3-cm incision over the posterior superior iliac crest, the
incision was carried down to bone, and the periosteum was
subperiosteally elevated to expose the outer table of the iliac
wing. A chisel and gouge were used to remove the outer
cortex of the iliac wing along with the underlying cancellous
bone. Hemostasis was achieved using bonewax and gel foam,
and the wound was irrigated with normal saline before
closure with absorbable sutures in layers. No drain was
placed. The amount of bone graft harvested was approxi-
mately the same between all subjects. A deepwound epidural
catheter was applied at the ICBG donor site to facilitate local
anesthetic infusion. Each subject also had access to morphine
patient-controlled analgesic (PCA) for up to 48 hours postop-
eratively per standard of care.
Intervention
The subjects were randomized into two groups. Group A
consisted of control subjects and group B consisted of treat-
ment subjects. Both groups received 5 mL of 0.5% levobupi-
vacaine locally at the ICBG site followed by 1-hour washout of
the single bolus injection. The single bolus injection was
performed as such to maintain the standard of care that
has been traditionally offered at our institute. After the bolus,
group A received an infusion of 3 mL of saline solution per
hour for 47 hours, and group B received continuous infusion
of 0.25% levobupivacaine 3 mL per hour for 47 hours at the
posterior iliac crest donor site. All subjectswereblinded to the
type of intervention they received (►Fig. 1). All patients
received standardized oral analgesics postoperatively. Para-
cetamol (1 g) was given four times daily, and 50 mg of oral
tramadol was given up to four times daily as needed.
Each subject was equipped with a continuous infusion
syringe pump for 48 hours. An InjectomatMC Agilia dose rate
syringe pump (Fresenius Kabi, Homburg, Germany) was
utilized to administer the local single dose bolus and contin-
uous anesthetic/saline infusion. The device allowed for a
programmable continuous ﬂow rate and accommodated a
50-mL syringe. To ensure the quality of the measurements
and minimize the risk of measurement error, the outcome
assessors underwent training to familiarize themselves with
the operation and programming of the syringe pump. The
syringe was reﬁlled every 16 hours. The investigators had
chosen a continuous infusion dose of 3 mL of 0.25% levobu-
pivacaine per hour, which was believed to be a safe, nontoxic
dose while maintaining a therapeutic beneﬁt.
On the day of the surgery, all patients were conﬁned to bed
rest. On the ﬁrst postoperative day, all patients were allowed
to sit in the bed and begin standing exercise if tolerable. All
patients began walking exercises on postoperative day 2.
Patients were discharged from the hospital when they were
able to ambulate independently and had a stable wound
condition.
Outcomes
The primary outcomes of the study entailed the preoperative
and postoperative assessment of donor site pain and the
amount of postoperative analgesic use. Pain assessment
was based on the visual analog scale (VAS) and the McGill
Pain Questionnaire.26 Pain at the donor site was assessed
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preoperatively and every 12 hours following surgery during
the course of hospitalization (minimum 5 days) by an indi-
vidual blinded to the intervention allocation of the patients.
In addition, the pain assessment of the primary spine surgical
site aswell as the contralateral region of the ICBG sitewas also
performed. The VAS score ranged from 0 to 10, with higher
scores noting more severe pain. The physical quality compo-
nent (potential score range: 0 to 45) of the McGill Pain
Questionnaire was used to assess the overall physical/bodily
pain, which translated as the higher the score, the worse
physical pain experience. All subjects at the time of assess-
ment were asked to rate their pain at its most severe.
Analgesic use was based on the morphine PCA usage, record-
ing the frequency of usage every hour for each postoperative
day. The PCA machine only allowed a preset dosage of
analgesic dependent on patient body weight within a
1-hour interval. The number of times patients reached the
maximum allowable dose was recorded. The patient and
outcome assessor were blinded to the treatment allocation
throughout the trial.
Each participant was evaluated for potential donor site
complications, such as, hematoma, infection, allergic re-
sponse, and overdose (convulsions, cardiac problems). Each
participant was assessed for the event of analgesic-related
complications, such as dizziness, nausea, and vomiting. In
addition, each participant was assessed during their course of
medical care throughout the year for any symptoms or
complications related to their primary spine surgery.
Participant demographics, surgical characteristics, and
management were tabulated, accounting for sex, age, body
weight and height, arm span, type of spinal deformity based
on the Lenke classiﬁcation,27 duration of surgery, vertebral
levels that were fused, and hospitalization duration. In addi-
tion, the study was monitored for safety and efﬁcacy of the
interventions. If at any point the investigators felt that the
study presented a known harm to the participant, the study
was terminated.
Randomization and Blinding
Block randomization was generated by a statistician, inde-
pendent of the outcome assessment, via a statistical program
to ensure equal intervention group assignment of 1:1. The
intervention assignment was concealed until the surgical
date. The participants and outcome assessors were blinded
to the type of intervention each group received.
Statistical Methods
All data was collected and coded upon a spreadsheet. The
SPSS version 21 (IBM, Chicago, Illinois, United States) statisti-
cal software program was utilized to perform the statistical
analyses. Descriptive and frequency analyses were conducted
of all data parameters. Signiﬁcance testing was performed,
whereby p values and 95% conﬁdence intervals were ob-
tained. If normal distribution was maintained, the indepen-
dent samples t test was used to assess the mean differences
between the groups. The paired samples t test was conducted
Fig. 1 Flowchart of study recruitment. Abbreviation: ICBG, autogenous iliac crest bone graft.
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to assess differences in the pre- and postoutcome parameters.
The Fisher exact test was utilized to assess proportional
differences between the categorical data parameters. Non-
parametric tests were considered accordingly. Evaluation of
the extreme outliers was assessed of all data points. If the
sample size allowed, subgroup analyses was considered and
based on subject demographic and spine-related deformity
parameters in relation to the postoperative pain parameters.
An intent-to-treat analysis was considered for participants
lost to follow-up or who withdrew from the study. All
statistical tests were two-sided. The threshold for statistical
signiﬁcance was p < 0.05.
Results
From February 2012 to July 2013, a total of 15 participants
were enrolled in this study. Three female participants (control
group) were excluded from the study: 2 due to infusion pump
blockage and 1 due to termination of the operation as a result
of intraoperative drop of motor evoked potential. As such, 12
subjects were included for this study (►Fig. 1). Five subjects
were allocated to group A (control group) and 7 were
allocated to group B (treatment group). There were 2 male
and 3 female subjects in group A, and 1 male and 6 female
subjects in group B (p ¼ 0.524). There were also no differ-
ences noted at baseline regarding age, weight, height, body
mass index, arm span, and length of hospitalization
(►Table 1). Details about the spinal deformity and operation
performed are listed in ►Table 2. There were no differences
between the groups for the type of spinal deformity
(p ¼ 0.794), number of fused levels (p ¼ 0.544), number of
instrumented levels (p ¼ 0.069), and duration of surgery
(p ¼ 0.285).
No statistically signiﬁcant difference was noted between
groups in pain scores at baseline (p > 0.05). Postoperatively,
no statistically signiﬁcant differencewas noted at the primary
spine surgical site between the groups throughout hospitali-
zation (p > 0.05). There was up to a twofold decrease in ICBG
and contralateral iliac crest pain in group B (cases) as com-
pared with group A (controls) in the ﬁrst 2 days after surgery,
which coincided with the conclusion of their 47-hour inter-
vention (p > 0.05; ►Fig. 2). The mean VAS pain scores at the
ICBG site during postoperative days 1 and 2 were 4.0 (stan-
dard deviation [SD]  3.7) and 3.4 (SD  2.2), respectively,
for group A. The mean VAS pain scores at the ICBG site during
days 1 and 2 were 2.6 (SD  2.8) and 2.3 (SD  1.8), respec-
tively, for group B. The mean VAS pain scores for the contra-
lateral iliac crest site during postoperative days 1 and 2 were
3.50 (SD:  4.1) and 1.2 (SD:  1.8), respectively, for group A.
The mean VAS pain scores during days 1 and 2 were 1.4
(SD:  1.9) and 0.6 (SD:  1.0), respectively, for group B. At
the conclusion of the intervention, the mean McGill pain
scores for group B (mean: 3.8; SD:  6.3) had approximately a
fourfold decrease as compared with controls (mean: 15.3;
SD:  14.8; p ¼ 0.158; ►Fig. 3).
The mean cumulative PCA morphine doses received at the
conclusion of the interventionwere 20.8 mg (SD:  13.0 mg)
and 25.7 mg (SD:  20.5 mg) for groups A and B, respectively
(p ¼ 0.650). However, 80% of group A as opposed to 72.1% of
group B had pressed the PCA buttonmore times than allowed
(p ¼ 1.000). Although these results were not statistically
signiﬁcant, those patientswho did not requiremore analgesia
than their PCA maximum had lower mean VAS pain scores in
the ﬁrst postoperative day at the primary surgical spine site
(2.3 versus 3), contralateral iliac crest site (0.5 versus 1), and
ICBG site (4 versus 6). This result was similar for the second
postoperative day for the primary surgical spine site (1.5
versus 3.5) and the ICBG site (3.8 versus 5.8). The contralateral
iliac crest pain on postoperative day 2 was the same (VAS 1)
for both groups.
Postoperative complications included only one wound
dehiscence noted at the ICBG site in group A, which required
a single debridement procedure and closure 5 days after the
initial surgery. No complications of hematoma, allergic re-
sponse, or overdose to medications were noted. There were
also no analgesic-related complications, such as dizziness,
nausea, or vomiting.
Discussion
Our level I randomized controlled trial is the ﬁrst in young
patients with AIS to assess the efﬁcacy of continuous anes-
thetic (i.e., levobupivacaine) infusion at the ICBG site in
comparison with a control group receiving saline. Our
Table 1 Study group characteristics
Variable Group A, control (n ¼ 5), mean (SD) Group B, treatment (n ¼ 7), mean (SD) p Value
Age (y) 15.9 (1.6) 15.3 (2.8) 0.720
Weight (kg) 55.1 (5.2) 45.8 (10.5) 0.104
Height (m) 1.7 (0.1) 1.5 (0.1) 0.084
BMI (kg/m2) 20.3 (4.0) 19.2 (2.9) 0.596
Arm span (cm) 165.4 (24.7) 155.3 (19.3) 0.524
Intraoperative time (min) 295.8 (72.6) 305.3 (61.7) 0.812
Number of instrumented levels 13.8 (1.8) 11.1 (2.5) 0.069
Length of hospitalization (d) 9 (2.0) 8 (0.8) 0.255
Abbreviations: BMI, body mass index; SD, standard deviation.
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Table 2 Characteristics of patients’ spinal deformity and operative proﬁle
Subject Group Sex Spinal deformity curve
type (classification)




1 Control F Main thoracic (Lenke 1) T2–T11 12 230
2 Treatment M Double thoracic (Lenke 2) T2–L2 15 360
3 Treatment F Double thoracic (Lenke 2) T2–T12 12 335
4 Control F Double thoracic (Lenke 2) T2–L2 14 229
5 Treatment F Double thoracic (Lenke 2) T2–L2 12 375
6 Treatment F Double major (Lenke 3) T4–L1 11 264
7 Control M Double thoracic (Lenke 2) T2–L2 15 300
8 Treatment F Thoracolumbar (Lenke 5) T8–L2 8 208
9 Control M Double thoracic (Lenke 2) T2–L3 16 405
10 Treatment F Double major (Lenke 3) T4–L1 12 335
11 Treatment F Main thoracic (Lenke 1) T6–T12 8 260
12 Control F Double major (Lenke 3) T5–L3 12 315
Abbreviation: PSF, posterior spinal fusion.
Note: “Control” is group A; “Treatment” is group B.
Fig. 2 Visual analog scale (VAS) pain assessment outcomes. (A) Pain at the iliac crest bone graft (ICBG) site and (B) pain at the contralateral iliac
crest site. Note that “Control” is group A and “Treatment” is group B.
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preliminary ﬁndings noted that continuous infusion of anes-
thetics decreased pain at the ICBG site almost twofold and
also decreased overall physical pain fourfold in a group of
Southern Chinese participants. These early ﬁndings are
promising as to the potential pain management options for
patients with AIS whereby bone graft is still harvested from
the iliac crest site.
Levobupivacaine is a local anesthetic that temporarily
inhibits sodium passage through voltage-gated ion channels
in the neuronal membrane, thereby allowing a reversible
transmission blockage of action potentials of sensory, motor,
and sympathetic nervous ﬁbers. Although excessive dose of
the anesthetic or accidental intravascular injectionmay affect
other ion channels and lead to central nervous and cardio-
vascular complications, themargin of safety of this anesthetic
is greater than its counterpart bupivacaine. Furthermore,
studies have noted the safety of levobupivacaine in the
pediatric population for continuous infusion application.28
Pain is a complex symptom that can be affected by many
parameters including patients’ pain perception and tolerance.
Although the cases and controls were similar in terms of PCA
usage, the individuals receiving continuous anesthetic infu-
sion (treatment group) reported a lower postoperative VAS
score and used the PCA button less than the control group. By
subclassifying the subjects into thosewhowere satisﬁedwith
the amount of analgesics given (not pressing the button more
than allowed) and those who were unsatisﬁed (pressing the
button more than the allowed dosage), we could see that the
latter group had worse VAS scores across all parameters as
compared with the former group. This observation implied
that despite having the same amount of analgesics, those
subjects with poor pain tolerance would likely require more
pain relief and rank their pain worse than others with better
pain tolerance. This ﬁnding wasmore signiﬁcant in our group
of patients because none of them knew whether they re-
ceived iliac crest infusion or saline and none of the subjects
had any adverse effects from PCA use including nausea or
vomiting. Likewise, subjects who had improved ICBG VAS
pain scores with iliac crest continuous anesthetic infusions
also had improved pain scores in the contralateral iliac crest.
This observation may be attributed to individual perception
of pain relief, referred pain, or perhaps an inability to distin-
guish the two sites in these young patients.
We would like to discuss several study limitations and
strengths. Our study did not achieve any statistically signiﬁ-
cant difference between different parameters following sur-
gery, which was attributed to the small sample size of our
recruitment. However, we did note trends of decreased pain,
approximately twofold, in patients who underwent continu-
ous infusion of levobupivacaine at the ICBG site compared
with the control group during the entire duration of such
intervention (i.e., the ﬁrst 47 hours after surgery). After the
interventions were not available, the pain severity normal-
ized between groups and was similar between all subjects.
Although our study is regarded as a pilot study, based on the
initial postoperative pain assessment, wehave calculated that
with 80% power and an α value of 0.05, a sample size of 87
subjects per study arm would be needed to demonstrate a
statistically signiﬁcant difference during the ﬁrst day follow-
ing surgery. Interestingly, to achieve a signiﬁcant effect for
overall physical pain relief via this intervention method, a
minimum of 16 subjects per study arm would be needed. As
such, our study forms the foundation for future, larger-scale
studies assessing such painmanagement in patients with AIS.
In addition, our study focused on a homogenous ethnic group
of Southern Chinese patients, which is a particular strength.
Ethnic variations may affect pain reporting and manage-
ment,29which further underscores the importance to address
pain parameters in AIS in a speciﬁed ethnic group, such as
Chinese, which represents a quarter of the world’s popula-
tion. Nonetheless, our ﬁndings, which noted a trend of
decreased pain with continuous anesthetic use at the ICBG
site compared with control subjects, further replicates what
other studies have noted in adult subjects and in non-Chinese
Fig. 3 McGill Pain Questionnaire scores assessing overall physical pain. Abbreviations: pre-op, preoperative; post-op, postoperative.
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patients.9,15,17–19 As such, our ﬁndings may be generalized to
other ethnic groups and populations.
Conclusions
To our knowledge, this study is the ﬁrst randomized con-
trolled trial to assess the efﬁcacy of continuous infusion of
analgesia into the ICBG site in young patients with AIS. The
preliminary results based on our pilot study have noted a
trend that continuous anesthetic infusion reduces pain over-
all and at the ICBG site. Such a ﬁnding may have potential to
improve postoperative pain management, which can lead to
further decreases in health care costs, improved utility, and
enhanced outcomes in young children with spinal deformi-
ties. However, larger studies are needed to further address
these issues and validate our preliminaryﬁndings, whichmay
affect clinical decision making. This study further established
a sample size calculation to facilitate future large-scale stud-
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